Acetylcysteine is a medication used to treat a variety of conditions, including acetaminophen overdose, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The global acetylcysteine market is expected to grow at a CAGR of 28.42% from 2022 to 2028. This growth is being driven by the increasing demand for acetylcysteine in the treatment of acetaminophen overdose, as well as the rising prevalence of COPD and cystic fibrosis. This article provides a list of the top global buyers of acetylcysteine. The list is based on a variety of factors, including the company’s size, annual revenue, and market share. The list is updated on a quarterly basis to ensure that it is…